Results 161 to 170 of about 84,212 (322)
Clinical Case Reports, Volume 13, Issue 12, December 2025.(A‐B) Patient 1 CT Imaging of sinuses before (A) and after (B) completing 2 months of steroid therapy for immune‐mediated sinusitis. ABSTRACT We present two novel cases of aseptic sinusitis resulting from PDL‐1 checkpoint inhibitor use. Prompt identification and diagnosis and a multidisciplinary approach with oncology and rheumatology are imperative ...
Josephine Yalovitser +4 more
wiley +1 more source
Journal of Clinical and Translational Endocrinology: Case Reports, 2021 K. Feghali +2 more
semanticscholar +1 more source
Severe Hypothyroidism‐Induced Rhabdomyolysis in the Absence of Triggering Factor
Clinical Case Reports, Volume 13, Issue 12, December 2025.ABSTRACT Rhabdomyolysis is a rare but serious complication of hypothyroidism that can occur even in the absence of external triggers or classical symptoms. Early recognition through creatinine kinase screening in high‐risk or atypical presentations is essential to prevent complications such as acute kidney injury and thus enable timely management.
Mohamed Haris Mohamed Azmi +6 more
wiley +1 more source
A case with isolated ACTH deficiency accompanying chronic thyroiditis.
, 1982 Keiichi Kamijo +5 more
openalex +2 more sources
Atopic Multimorbidity in Adults With a Focus on Sensitization Patterns and T Cell Activation
Clinical and Translational Allergy, Volume 15, Issue 12, December 2025.Our study looked at atopic dermatitis and atopic comorbidities (rhinitis, asthma) with regards to type 1 allergic sensitizations, serum IgE values and systemic T cell activation. Our results show that IgE values increase with atopic disease burden while T cell activation is rather dependent on disease activity than atopic multimorbidity.
Ariane Bialas +6 more
wiley +1 more source
Immunotherapy‐Related Gastritis in Small Cell Lung Cancer Treatment With Durvalumab—A Case Report
Cancer Reports, Volume 8, Issue 12, December 2025.ABSTRACT Background Durvalumab is a PD‐L1 inhibitor that triggers a blockade resulting in enhanced anti‐tumor responses related to increased T‐cell activation. There is potential for numerous immune‐related adverse events (irAEs) with this treatment, most of which have been shown to be effectively managed with high‐dose steroids.
Marc C. Cavaliere +2 more
wiley +1 more source
Popular co-occurrence of thyroid autoimmune disorders and specific gastrointestinal tract diseases
Journal of Education, Health and Sport, 2019 Introduction: Thyroid gland, despite of its small average size, is a crucial organ of human body. Hormones produced by the thyroid i.e. thyroxine (T4) and triiodothyronine (T3) are necessary for proper functioning the whole organism.
Ewa Tywanek +3 more
doaj
Comprehensive Physiology, Volume 15, Issue 6, December 2025.Semaglutide, GLP‐1 receptor agonist, offers metabolic benefits that far outweigh those offered by comparable caloric restriction. Its mechanism of action involves hypophagia but also adipose tissue remodeling and browning. Semaglutide targeted thermogenesis via alternation in the thyroid axis and sympathetic input to BAT.
Suyeun Byun +6 more
wiley +1 more source